Literature DB >> 26065997

Low-Density Lipoprotein Particle Number Is Associated With Cardiovascular Events Among Those Not Classified Into Statin Benefit Groups.

Olle Melander, Dov Shiffman, Michael P Caulfield, Judy Z Louie, Charles M Rowland, James J Devlin, Ronald M Krauss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26065997     DOI： 10.1016/j.jacc.2015.02.077

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

1.  Saturated Fat Consumption and Risk of Coronary Heart Disease and Ischemic Stroke: A Science Update.

Authors:  Joyce A Nettleton; Ingeborg A Brouwer; Johanna M Geleijnse; Gerard Hornstra
Journal:  Ann Nutr Metab       Date:  2017-01-27       Impact factor: 3.374

2.  Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.

Authors:  Samia Mora; Michael P Caulfield; Jay Wohlgemuth; Zhihong Chen; H Robert Superko; Charles M Rowland; Robert J Glynn; Paul M Ridker; Ronald M Krauss
Journal:  Circulation       Date:  2015-09-25       Impact factor: 29.690

3.  Use of low density lipoprotein particle number levels as an aid in statin treatment decisions for intermediate risk patients: a cost-effectiveness analysis.

Authors:  Dov Shiffman; Andre R Arellano; Michael P Caulfield; Judy Z Louie; Lance A Bare; James J Devlin; Olle Melander
Journal:  BMC Cardiovasc Disord       Date:  2016-12-07       Impact factor: 2.298

4.  Comparison of Two Nuclear Magnetic Resonance Spectroscopy Methods for the Measurement of Lipoprotein Particle Concentrations.

Authors:  Martin Rief; Reinhard Raggam; Peter Rief; Philipp Metnitz; Tatjana Stojakovic; Markus Reinthaler; Marianne Brodmann; Winfried März; Hubert Scharnagl; Günther Silbernagel
Journal:  Biomedicines       Date:  2022-07-21

Review 5.  CVD Risk Stratification in the PCSK9 Era: Is There a Role for LDL Subfractions?

Authors:  Christian Abendstein Kjellmo; Anders Hovland; Knut Tore Lappegård
Journal:  Diseases       Date:  2018-05-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.